Alex Stockdale
@alexstockdale.bsky.social
Senior Clinical Lecturer in Infectious Diseases at the University of Liverpool and Malawi Liverpool Wellcome Research Programme.
Epidemiology, virology and implementation science.
Interested in eliminating hepatitis B as a public health threat in Africa.
Epidemiology, virology and implementation science.
Interested in eliminating hepatitis B as a public health threat in Africa.
There’s a problem with the first chart- the UK’s GDP looks to be less than Russia’s (width of bars) whereas the reverse is true.
November 3, 2025 at 4:07 AM
There’s a problem with the first chart- the UK’s GDP looks to be less than Russia’s (width of bars) whereas the reverse is true.
Completely agree. Our review earlier this year in Lancet Gastro Hep also showed low rates of retention in care for HBV across multiple settings. We have a lot to learn from HIV.
October 16, 2025 at 7:55 AM
Completely agree. Our review earlier this year in Lancet Gastro Hep also showed low rates of retention in care for HBV across multiple settings. We have a lot to learn from HIV.
Denial, anger, bargaining, depression and acceptance?
August 18, 2025 at 6:13 PM
Denial, anger, bargaining, depression and acceptance?
August 17, 2025 at 10:41 AM
8/ HBV antiviral treatment prevents HCC and improves survival- and is cheap and effective. We need urgent improvements to our service delivery to address a leading cause of liver related death globally.
August 17, 2025 at 10:27 AM
8/ HBV antiviral treatment prevents HCC and improves survival- and is cheap and effective. We need urgent improvements to our service delivery to address a leading cause of liver related death globally.
7/ our care cascade shows huge losses at every step of patient care and we need to learn how to do it better- learning from HIV care. Implementation research, better training and equipping of primary or decentralised care is needed to promote access to care
August 17, 2025 at 10:27 AM
7/ our care cascade shows huge losses at every step of patient care and we need to learn how to do it better- learning from HIV care. Implementation research, better training and equipping of primary or decentralised care is needed to promote access to care
6/ some innovative community models linked to dedicated research clinics had very good rates of assessment and treatment initiation but the long term outcomes are lacking.
August 17, 2025 at 10:27 AM
6/ some innovative community models linked to dedicated research clinics had very good rates of assessment and treatment initiation but the long term outcomes are lacking.
5/ really serious losses observed in linking pregnant women to HBV care after delivery- 56·9% (40·2–72·1; I2=98·8%) linked to care (five cohorts) and when community screening led to self-directed care (without follow up arrangements) 33·2% (23·1–45·1; I2=98·6%)
August 17, 2025 at 10:27 AM
5/ really serious losses observed in linking pregnant women to HBV care after delivery- 56·9% (40·2–72·1; I2=98·8%) linked to care (five cohorts) and when community screening led to self-directed care (without follow up arrangements) 33·2% (23·1–45·1; I2=98·6%)
4/ retention in care is a real problem and especially among patients not started on antiviral treatment - RR 1·72 [95% CI 1·16–2·54]; p=0·019 for retention in care for those on AVT vs not
August 17, 2025 at 10:27 AM
4/ retention in care is a real problem and especially among patients not started on antiviral treatment - RR 1·72 [95% CI 1·16–2·54]; p=0·019 for retention in care for those on AVT vs not
3/ 12% don’t commence antiviral therapy when eligible, again it is worse in primary or co-managed care
August 17, 2025 at 10:27 AM
3/ 12% don’t commence antiviral therapy when eligible, again it is worse in primary or co-managed care
2/ over 15% don’t complete an assessment of their treatment eligibility in specialist care and it is worse in co-managed and primary care.
August 17, 2025 at 10:27 AM
2/ over 15% don’t complete an assessment of their treatment eligibility in specialist care and it is worse in co-managed and primary care.
Never let excel get anywhere near dates! It’s a menace
July 2, 2025 at 9:59 AM
Never let excel get anywhere near dates! It’s a menace
They did emphasise shared decision making which is a great idea
May 10, 2025 at 1:28 PM
They did emphasise shared decision making which is a great idea
Much clearer, simpler and easier to implement in practice. A job well done
May 10, 2025 at 12:53 PM
Much clearer, simpler and easier to implement in practice. A job well done
But for HBeAg positive young people, no recommendation for treatment, given a lack of strong evidence of benefit
May 10, 2025 at 12:53 PM
But for HBeAg positive young people, no recommendation for treatment, given a lack of strong evidence of benefit
Elevated ALT and HBV DNA >2000, or LSM>8kPa and detectable HBV DNA are the main criteria, liberalising treatment thresholds.
May 10, 2025 at 12:51 PM
Elevated ALT and HBV DNA >2000, or LSM>8kPa and detectable HBV DNA are the main criteria, liberalising treatment thresholds.
What are the three platforms?
May 6, 2025 at 7:14 AM
What are the three platforms?
Demonise and Oppress Government Employees
February 28, 2025 at 11:12 AM
Demonise and Oppress Government Employees